<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="154784">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02000791</url>
  </required_header>
  <id_info>
    <org_study_id>laryngeal mask</org_study_id>
    <nct_id>NCT02000791</nct_id>
  </id_info>
  <brief_title>Does Laryngoscopic Tecnique Facilitate cLMA Insertion?</brief_title>
  <acronym>cLMA</acronym>
  <official_title>Does Laryngoscopic Tecnique Facilitate cLMA Insertion?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diskapi Yildirim Beyazit Education and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diskapi Yildirim Beyazit Education and Research Hospital</source>
  <oversight_info>
    <authority>Turkey: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      it is compared that  laryngeal mask insertion with standard technique and laryngoscopic
      technique
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Is there any releation between insertion succes rate and difficult intubation criteria.
      success of the first attempt laryngeal mask insertion, patient response of laryngeal mask
      placement.  And also during the implementation of these two techniques; the effects on heart
      rate and blood pressure and postoperative complications were investigated.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>İnvestigate to easy of insertion whether standart or laryngoscopic technique</measure>
    <time_frame>1 min after insertion</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fiberoptic view</measure>
    <time_frame>1 min after insertion</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Urologic Surgery</condition>
  <arm_group>
    <arm_group_label>cLMA insertion via laryngoscopic technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Comparison of cLMA insertion via laryngoscope view by fiberscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>cLMA insertion via standart technique</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Comparison of cLMA insertion via standart technique view by fiberscope</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Comparison of fibreoptic view</intervention_name>
    <arm_group_label>cLMA insertion via laryngoscopic technique</arm_group_label>
    <arm_group_label>cLMA insertion via standart technique</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Over 18 age

          -  under urologic surgery patient

        Exclusion Criteria:

          -  Uper respiratory infection

          -  Full stomach

          -  BMI over 40
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Tugba Arslan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>xxxx</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tuğba Arslan, MD</last_name>
    <phone>+905074378919</phone>
    <email>tuba.kokulu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diskapi Yildiim Beyazit Eduation and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Murat Alper, MD</last_name>
      <phone>+905326734310</phone>
    </contact>
    <investigator>
      <last_name>Tuğba Arslan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <lastchanged_date>December 3, 2013</lastchanged_date>
  <firstreceived_date>November 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Diskapi Yildirim Beyazit Education and Research Hospital</investigator_affiliation>
    <investigator_full_name>Tugba Arslan</investigator_full_name>
    <investigator_title>medical doctor</investigator_title>
  </responsible_party>
  <keyword>cLMA</keyword>
  <keyword>laryngoscopy</keyword>
  <keyword>fiberoptic</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
